Beryl Drugs share news, announcements and annual reports
BSE: 524606Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 30 Oct 2026. Previous close ₹25.00.
30 Oct: open ₹27.00, high ₹27.00, low ₹23.00
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹13 Cr4,587th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 20.79
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.31
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 6.4%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 3.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.24
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 2,166
Beryl Drugs share news and announcements
572 announcements, routine notices left out, newest first. Page 9 of 12.
May 2018
31 May · Board meeting
22 May · MEETING OF BOARD OF DIRECTORS UNDER REGULATION 29 OF THE SEBI (LISTING OBLIGATIONS AND DISCLOSURES REQUIREMENT)REGULATION 2015 ON 30TH MAY 2018
Apr 2018
18 Apr · Board meeting
18 Apr · Board meeting
16 Apr · Shareholding for the Period Ended March 31, 2018
Shareholding Pattern for the Period Ended March 31, 2018. For more details, kindly Click ....10 Apr · 16TH MEETING OF THE BOARD OF DIRECTORS WILL BE HELD ON 18TH APRIL, 2018
7 Apr · COMPLIANCES
7 Apr · COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 31ST MARCH 2018
7 Apr · Statement Of Investor Complaints For The Quarter Ended March 2018
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 0 0 0
Mar 2018
Feb 2018
9 Feb · Board meeting
1 Feb · BOARD MEETING ON 9TH FEBRUARY 2018
Jan 2018
11 Jan · Shareholding for the Period Ended December 31, 2017
Shareholding Pattern for the Period Ended December 31, 2017. For more details, kindly Click ....
Dec 2017
Nov 2017
4 Nov · Results
4 Nov · Board meeting
Oct 2017
27 Oct · BOARD MEETING ON 4TH NOVEMBER 2017
11 Oct · COMPLIANCE CERTIFICATE FOR THE QUARTER ENDED 30TH SEPTEMBER, 2017
11 Oct · PCS CERTIFICATE FOR THE QUARTER ENDED 30TH SEPTEMBER, 2017
11 Oct · STATEMENT OF INVESTOR COMPLAINT FOR THE QUARTER ENDED 30TH SEPTEMBER, 2017
11 Oct · Shareholding for the Period Ended September 30, 2017
Shareholding Pattern for the Period Ended September 30, 2017. For more details, kindly Click ....
Sep 2017
Aug 2017
28 Aug · Results
Details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....28 Aug · Meeting
28 Aug · Meeting
26 Aug · Meeting
18 Aug · Results
2 Aug · Meeting
Jul 2017
13 Jul · Results
7 Jul · Meeting
7 Jul · Results
7 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....
Jun 2017
May 2017
30 May · Results
30 May · Board meeting
Apr 2017
10 Apr · Compliance Certificate For The Period Ended 31St March, 2017
10 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....10 Apr · Statement Of Investor Complaints For The Period Ended 31St March, 2017
10 Apr · Compliance Certificate For The Period Ended 31St March 2017
4 Apr · 11TH BOARD MEETING OF THE COMPANY WILL BE HELD ON 12TH DAY OF APRIL, 2017 AT 12:00 PM AT THE REGISTERED OFFICE OF THE COMPANY, 133, KANCHAN BAGH, INDORE- 452001